Using Doxil for Multiple MyelomaMultiple myeloma is cancer that begins in plasma cells (a type of white blood cell). Myeloma begins when a plasma cell becomes abnormal. The abnormal cell makes copies of itself by dividing again and again, making more and more abnormal cells. The abnormal plasma cells are myeloma cells.
- Make antibodies called M proteins
- Collect in the bone marrow
- May crowd out normal blood cells
- Collect in the solid part of the bone.
The disease is called "multiple myeloma" because it affects many bones. If myeloma cells collect in only one bone, the single mass is called a plasmacytoma. Multiple myeloma is the most common type of plasma cell tumor.
Doxil is approved to be used in combination with bortezomib (Velcade®) to treat multiple myeloma in people who have not yet received bortezomib treatment but have tried at least one other type of treatment.
Doxil Uses for Ovarian CancerOvarian cancer is a disease in which cancerous cells form in the tissues of the ovaries. Women with this type of cancer have many treatment options available to them, including:
- Surgery (see Ovarian Cancer Surgery)
- Radiation therapy (see Ovarian Cancer Radiation)
- Chemotherapy (see Ovarian Cancer Chemotherapy).
Many women receive more than one type of treatment.
Doxil is used to treat ovarian cancer in women whose disease has progressed despite treatment with platinum-based chemotherapy (any medication that has "platin" in the name).